Venetoclax for multiple myeloma - mechanism of action and next steps
Clinically relevant side effects of BiTE immunotherapy and other T-cell therapies
How can standard risk multiple myeloma (MM) patients be cured?
Overview of the GALLIUM study
What’s next for rare myelomas?